ArticleBMC research notes2022

Efficacy of SGLT2 inhibitors as additional treatment in Japanese type 2 diabetic patients: second or third choice?

Makoto Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.